Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBL-514 for Reducing Abdominal Subcutaneous Fat
NCT07140939Phase 3Recruiting
- Sponsor
- Caliway Biopharmaceuticals
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of CBL-514 in subcutaneous fat, sponsored by Caliway Biopharmaceuticals. Started Sep 2026; status: recruiting.
02
Drugs
CBL-514
03
Conditions
subcutaneous fat
Beyond the preview
Go deeper on NCT07140939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07140939.